Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kelly Makarounas‐Kirchmann"'
Autor:
Matt Franklin, Francis Shupo, Emily Jones, Nicola Mason, Grace Wayi-Wayi, Karan Kanhai, Natasa Zibelnick, Mileva Repasky, Kelly Makarounas-Kirchmann, Sudipto Mukherjee, John Brazier
Publikováno v:
HemaSphere, Vol 7, p e69432f9 (2023)
Externí odkaz:
https://doaj.org/article/20c8c50023504171b35f1e6c71d49a27
Publikováno v:
Journal of sleep researchREFERENCES.
Obstructive sleep apnea (OSA) is a common disorder. OSA is associated with cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM) and depression, among other comorbidities. We aim to determine the productivity burden of OSA in Australia using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74da5c4b6660cd4a3e5415a63bcacee5
https://pubmed.ncbi.nlm.nih.gov/36303525
https://pubmed.ncbi.nlm.nih.gov/36303525
Publikováno v:
Diabetes Research and Clinical Practice. 164:108158
FreeStyle Libre™ Flash Glucose Monitoring System (Flash GM), a novel, sensor-based, factory-calibrated system has been compared with self-monitoring of blood glucose in a well-controlled adult type 1 diabetes mellitus (T1D) population (HbA1c ≤ 7.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955461ddb097e1d50a8b73c650a5b1c4
https://doi.org/10.1016/j.diabres.2020.108158
https://doi.org/10.1016/j.diabres.2020.108158
Autor:
Johannes Uiltje Stoelwinder, Kelly Makarounas-Kirchmann, Emma Louise Ashton, Lisa L Ioannides-Demos, John J McNeil
Publikováno v:
Clinical drug investigation. 30(8)
Background: In order to evaluate the cost effectiveness of preventive strategies for myocardial infarction (MI), direct cost estimates are required. However, Australian-specific cost estimates for MI are not available. Objective: The CosMIC (Cost of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f47f2cff0c0c9d96549fcfe67089e8b
https://pubmed.ncbi.nlm.nih.gov/20527994
https://pubmed.ncbi.nlm.nih.gov/20527994
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 9, Iss 6, Pp 63-73 (2010)
Background: Results from clinical studies suggest that the dihydropyridine calcium channel blocker (CCB) lercanidipine may be associated with a lower incidence of peripheral edema than are older dihydro-pyridine CCBs. Objective: The objective of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40068651fac4b3ba57ce87f30379c91b
https://pubmed.ncbi.nlm.nih.gov/20206797
https://pubmed.ncbi.nlm.nih.gov/20206797
Publikováno v:
Monash University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::259ab67f1707c8ed084f9662ff4f96a8
https://research.monash.edu/en/publications/271fc499-c768-4df7-adfc-e47fb182adfb
https://research.monash.edu/en/publications/271fc499-c768-4df7-adfc-e47fb182adfb
Publikováno v:
Macquarie University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::69660da32e592c694d4b580716c1db0c
https://researchers.mq.edu.au/en/publications/59ca6363-5f4c-458e-833f-21e953888620
https://researchers.mq.edu.au/en/publications/59ca6363-5f4c-458e-833f-21e953888620